SMAD4 and colorectal carcinoma: To achieve this, we employed a genetic CRC mouse model with tissue-specific deletion of the canonical SMAD4 signaling protein in the intestinal epithelial cells to determine how removal of this pathway alters colonic activation of the PI3K/AKT pathway and survival in vivo.